Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Has announcements × Cystectomy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 44 Carboplatin 39 Cisplatin 36 Paclitaxel 27 Pemetrexed 24 Nivolumab 24 Gemcitabine 23 Dexamethasone 21 Rituximab 18 Ipilimumab 16 Fluorouracil 14 Cyclophosphamide 14 Docetaxel 13 Capecitabine 13 atezolizumab 12 Lenalidomide 12 durvalumab 11 daratumumab 11 Trastuzumab 11 Cytarabine 11 trastuzumab deruxtecan 10 olaparib 10 Prednisone 10 Bortezomib 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 9 Oxaliplatin 8 Doxorubicin 8 Crizotinib 8 zanubrutinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03924895 2025-08-28

KEYNOTE-905

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

595 enrolled 2 FDA

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡